Research and Development (R&D) Activities of the Indian Pharmaceutical Companies

Mithun Nandy ()
Additional contact information
Mithun Nandy: Hegde & Hegde Pharmaceutica LLP

Chapter Chapter 4 in Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry, 2022, pp 75-104 from Springer

Abstract: Abstract In pharmaceutical industry, R&D can be considered as any activity to resolve scientific uncertainty and unknown targeted at accomplishing an advance in science by answering the unknown for treating different novel diseases or disorders. In pharmaceutical industry, R&D activities are related to the innovative work undertaken on a scientific method for the advancement of knowledge including search of ‘new molecular entity’ synthesis and modification of known molecules or some methods to boost production rate by adopting different tools and techniques.

Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-981-16-6921-7_4

Ordering information: This item can be ordered from
http://www.springer.com/9789811669217

DOI: 10.1007/978-981-16-6921-7_4

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().